| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 683252 | Null | 0.00662388971299133 | 0.56740666 |
| NSC 692581 | Null | 0.00662388971299133 | 0.40683693 |
| NSC 694485 | Benzoic acid, 4-[[(2,4-diaminopteridinyl)-6-methyl] (formyl)amino]- | 0.00662388971299133 | 0.39324612 |
| NSC 708419 | Null | 0.00662388971299133 | 0.34615921 |
| NSC 727284 | 2-Bromo-3-methoxy-6-(methylamino)-9,10-dihydrdo-9,10-[1,2]be nzenoanthracene-1,4,5,8-tetraone. | 0.00662388971299133 | 0.17496202 |
| NSC 757113 | METHOTREXATE(+/-) | 0.00662388971299133 | 0.36480402 |
| NSC 112758 | Rubomycin | 0.00662388971299138 | 0.48123355 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.00662388971299138 | 0.41115315 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.00662388971299138 | 0.53897679 |
| NSC 134725 | K-33 | 0.00662388971299138 | 0.65678763 |